-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Ginkgo Bioworks Holdings, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2020 to Q3 2024.
- Ginkgo Bioworks Holdings, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$375K, a 1605% decline year-over-year.
- Ginkgo Bioworks Holdings, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was -$352K, a 97.6% increase year-over-year.
- Ginkgo Bioworks Holdings, Inc. annual Income Tax Expense (Benefit) for 2023 was -$71K, a 99.5% increase from 2022.
- Ginkgo Bioworks Holdings, Inc. annual Income Tax Expense (Benefit) for 2022 was -$15M, a 915% decline from 2021.
- Ginkgo Bioworks Holdings, Inc. annual Income Tax Expense (Benefit) for 2021 was -$1.48M, a 178% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)